MESO Stock Summary and Trading Ideas (Mesoblast Limited - American Depositary Shares | NASDAQ:MESO)

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.

Mesoblast Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol MESO.

As of March 11, 2026, MESO stock price declined to $15.63 with 86,179 million shares trading.

MESO has a beta of 1.74, meaning it tends to be more sensitive to market movements. MESO has a correlation of 0.18 to the broad based SPY ETF.

MESO has a market cap of $2.02 billion. This is considered a Mid Cap stock.

Last quarter Mesoblast Limited - American Depositary Shares reported $51 million in Revenue and -$.03 earnings per share. This beat revenue expectation by $34 million and exceeded earnings estimates by $.17.

In the last 3 years, MESO traded as high as $22.00 and as low as $1.61.

The top ETF exchange traded funds that MESO belongs to (by Net Assets): IBB, IBBQ, APIE, BIB.

MESO has underperformed the market in the last year with a price return of +19.6% while the SPY ETF gained +21.9%. MESO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -18.0% and -5.4%, respectively, while the SPY returned -1.3% and -1.6%, respectively.

MESO support price is $15.12 and resistance is $16.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MESO shares will trade within this expected range on the day.